Cargando…
25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)(2)D(3)
Cholangiocarcinoma (CCA) is a devastating disease without effective treatments. 1α,25(OH)(2)D(3), the active form of Vitamin D, has emerged as a new anti-cancer regimen. However, the side effect of hypercalcemia impedes its systemic administration. 25(OH)D is biologically inert and needs hydroxylati...
Autores principales: | Chiang, Kun-Chun, Yeh, Chun-Nan, Huang, Cheng-Cheng, Yeh, Ta-Sen, S. Pang, Jong-Hwei, Hsu, Jun-Te, Chen, Li-Wei, Kuo, Sheng-Fong, Kittaka, Atsushi, Chen, Tai C., Juang, Horng-Heng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000723/ https://www.ncbi.nlm.nih.gov/pubmed/27529229 http://dx.doi.org/10.3390/ijms17081326 |
Ejemplares similares
-
Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)(2)D, but No Difference in Ratio of 25(OH)D/24,25(OH)(2)D and FGF23 Concentrations
por: Vlot, Mariska C, et al.
Publicado: (2019) -
Association among plasma 1,25(OH)(2)D, ratio of 1,25(OH)(2)D to 25(OH)D, and prostate cancer aggressiveness
por: Ramakrishnan, Swathi, et al.
Publicado: (2019) -
Predictors of 25(OH)D half-life and plasma 25(OH)D concentration in The Gambia and the UK
por: Jones, K. S., et al.
Publicado: (2014) -
Bioavailable 25(OH)D but Not Total 25(OH)D Is an Independent Determinant for Bone Mineral Density in Chinese Postmenopausal Women
por: Li, Chenguang, et al.
Publicado: (2016) -
25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study
por: Ratzinger, Franz, et al.
Publicado: (2017)